Literature DB >> 16280550

Secrets of a double agent: CDK7 in cell-cycle control and transcription.

Robert P Fisher1.   

Abstract

In metazoans, cyclin-dependent kinase 7 (CDK7) has essential roles in both the cell-division cycle and transcription, as a CDK-activating kinase (CAK) and as a component of the general transcription factor TFIIH, respectively. Controversy over its double duty has been resolved, but questions remain. First, how does CDK7 achieve the dual substrate specificity necessary to perform both roles? Second, is there a deeper connection implied by the dichotomy of CDK7 function, for example similar mechanisms controlling cell division and gene expression, and/or actual coordination of the two processes? Enzymological studies have revealed solutions to the unusual substrate recognition problem, and there is evidence that the distinct functions of CDK7 can be regulated independently. Finally, despite divergence in their wiring, the CAK-CDK networks of budding yeast, fission yeast and metazoans all link transcriptional regulation with operation of the cell-cycle machinery. This connection might help to ensure that mRNAs encoding effectors of cell division are expressed at the right time in the cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280550     DOI: 10.1242/jcs.02718

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  109 in total

1.  Requirements for Cdk7 in the assembly of Cdk1/cyclin B and activation of Cdk2 revealed by chemical genetics in human cells.

Authors:  Stéphane Larochelle; Karl A Merrick; Marie-Emilie Terret; Lara Wohlbold; Nora M Barboza; Chao Zhang; Kevan M Shokat; Prasad V Jallepalli; Robert P Fisher
Journal:  Mol Cell       Date:  2007-03-23       Impact factor: 17.970

Review 2.  TFIIH: when transcription met DNA repair.

Authors:  Emmanuel Compe; Jean-Marc Egly
Journal:  Nat Rev Mol Cell Biol       Date:  2012-05-10       Impact factor: 94.444

3.  High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma.

Authors:  Philip Eliades; Brian J Abraham; Zhenyu Ji; David M Miller; Camilla L Christensen; Nicholas Kwiatkowski; Raj Kumar; Ching Ni Njauw; Michael Taylor; Benchun Miao; Tinghu Zhang; Kwok-Kin Wong; Nathanael S Gray; Richard A Young; Hensin Tsao
Journal:  J Invest Dermatol       Date:  2018-02-08       Impact factor: 8.551

4.  A phosphorylation-independent role for the yeast cyclin-dependent kinase activating kinase Cak1.

Authors:  Su-Hwa Kim; Keerthi Gadiparthi; Stephen J Kron; Ana A Kitazono
Journal:  Gene       Date:  2009-07-30       Impact factor: 3.688

5.  Cyclic AMP inhibits the proliferation of thyroid carcinoma cell lines through regulation of CDK4 phosphorylation.

Authors:  Ana Sofia Rocha; Sabine Paternot; Katia Coulonval; Jacques E Dumont; Paula Soares; Pierre P Roger
Journal:  Mol Biol Cell       Date:  2008-09-17       Impact factor: 4.138

6.  All-atomic molecular dynamic studies of human CDK8: insight into the A-loop, point mutations and binding with its partner CycC.

Authors:  Wu Xu; Benjamin Amire-Brahimi; Xiao-Jun Xie; Liying Huang; Jun-Yuan Ji
Journal:  Comput Biol Chem       Date:  2014-04-03       Impact factor: 2.877

7.  Ancestral reconstruction reveals mechanisms of ERK regulatory evolution.

Authors:  Dajun Sang; Sudarshan Pinglay; Rafal P Wiewiora; Myvizhi E Selvan; Hua Jane Lou; John D Chodera; Benjamin E Turk; Zeynep H Gümüş; Liam J Holt
Journal:  Elife       Date:  2019-08-13       Impact factor: 8.140

8.  CDK regulation of transcription by RNAP II: Not over 'til it's over?

Authors:  Robert P Fisher
Journal:  Transcription       Date:  2016-12-22

Review 9.  Cell cycle, CDKs and cancer: a changing paradigm.

Authors:  Marcos Malumbres; Mariano Barbacid
Journal:  Nat Rev Cancer       Date:  2009-03       Impact factor: 60.716

Review 10.  Cyclin-dependent kinase inhibitor drugs as potential novel anti-inflammatory and pro-resolution agents.

Authors:  A E Leitch; C Haslett; A G Rossi
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.